Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India · Delayed Price · Currency is INR 61.81
+2.94 (4.99%)
May 25, 2026, 9:49 AM IST
NSE:KREBSBIO Market Cap
NSE:KREBSBIO has a market cap or net worth of 1.22 billion as of May 22, 2026. Its market cap has decreased by -28.44% in one year.
Market Cap
1.22B
Enterprise Value
3.47B
Revenue
257.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.81
Market Cap Chart
Since January 2, 2004, NSE:KREBSBIO's market cap has decreased from 1.64B to 1.22B, a decrease of -25.68%. That is a compound annual growth rate of -1.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.22B | -18.87% |
| Dec 31, 2025 | 1.50B | -24.71% |
| Dec 31, 2024 | 1.99B | 18.08% |
| Dec 29, 2023 | 1.69B | -29.33% |
| Dec 30, 2022 | 2.39B | -45.14% |
| Dec 31, 2021 | 4.36B | 60.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 7.78B |
| Valiant Laboratories | 4.18B |
| Bafna Pharmaceuticals | 3.19B |
| Nectar Lifesciences | 2.37B |
| Brooks Laboratories | 1.58B |
| Alpa Laboratories | 1.46B |
| Balaxi Pharmaceuticals | 1.38B |
| Par Drugs and Chemicals | 1.06B |